Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

CLOTRIMAZOLE 1% SOLUTION

CLOTRIMAZOLE
$2.6694per ML
OTC

Strength

1 g/100mL

Manufacturer

Rugby Laboratories

NDC

00536144370

Classification

Generic

Dosage Form

SOLUTION

Route

TOPICAL

Last Updated

4/22/2026

Active Ingredients

CLOTRIMAZOLE

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M005

On Market Since

11/21/2024

Pharmacological Classes

Azole Antifungal
Azoles

Price History

1W

0.0%

1M

+0.7%

3M

+4.9%

6M

+23.9%

1Y

N/A

3Y

N/A

5Y

N/A

All

+6.0%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

ATHLETE'S FOOT 2% POWDER SPRAY
Generic
70000032101•Cardinal Health
$0.0362
per GM
CLOTRIMAZOLE 1% TOPICAL CREAM
Generic
00536126526•Rugby Laboratories
$0.0494
per GM
GNP MICONAZORB AF 2% POWDER
Generic
46122044427•AmerisourceBergen
$0.0579
per GM
GNP MICONAZORB AF 2% POWDER
Generic
46122078929•AmerisourceBergen
$0.0579
per GM
ANTIFUNGAL 2% POWDER
Generic
70000032301•Cardinal Health
$0.0579
per GM
ANTIFUNGAL 2% POWDER
Generic
70000067901•Cardinal Health
$0.0579
per GM
BAZA ANTIFUNGAL 2% CREAM
Generic
11701004514•Coloplast Manufacturing US, LLC
$0.0585
per GM
CLOTRIMAZOLE 1% TOPICAL CREAM
Generic
00536126595•Rugby Laboratories
$0.0639
per GM
METRONIDAZOLE 250 MG TABLET
Generic
00904715661•Major Pharmaceuticals
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
16571066501•Rising Pharma Holdings Inc.
$0.0791
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy